newsfilter
← Latest News
ACCESS Newswire·

Biophytis Announces the Design of its Phase 2 OBA Clinical Study in Obesity

PARIS, FRANCE and CAMBRIDGE, MA / ACCESSWIRE / May 14, 2024 / Biophytis SA , , a clinical-stage biotechnology company specialized in the development of